Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome

Recruiting

Phase 1

Pulsatile FSHUse of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome

Sponsor:

University of Colorado, Denver

Code:

NCT06414096

Conditions

Infertility

Obesity

Eligibility Criteria

Sex: Female

Age: 19 - 37

Healthy Volunteers: Accepted

Interventions

Follicle Stimulating Hormone

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-25. This information was provided to ClinicalTrials.gov by University of Colorado, Denver on 2024-11-27.